13.12.2018 03:48:06

J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases

(RTTNews) - Johnson & Johnson (JNJ) is willing to pay more than $400 million to settle some of the thousands of consumers' allegations that the company sold defective artificial hips and hid the health risks of the devices, Bloomberg reported citing people familiar with the matter.

The company has settled, or is in the process of settling, about 3,300 of 10,000 lawsuits targeting its Pinnacle line of hip-replacement devices, a judge reportedly said in a December 9 court filing.

J&J officials have agreed to pay an average of about $125,000 per case to resolve about a third of the suits pending against the company over Pinnacle hips, the report said.

An average payout of $125,000 for 3,300 cases would cost the company about $413 million.

J&J is seeking to resolve the remaining Pinnacle cases before a trial gets underway in January, the people added. Talks are continuing with lawyers for the residual hip recipients who have sued, the report said.

The accords are the first settlements in the bitter seven-year litigation battle over the metal-on-metal hip implants, which some consumers say failed prematurely or gave them metal poisoning. J&J's DePuy unit made the hips, which were taken off the market in 2013.

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 139,26 0,32% Johnson & Johnson